company background image
DOCS logo

Doximity NYSE:DOCS Stock Report

Last Price

US$52.85

Market Cap

US$9.9b

7D

3.1%

1Y

104.3%

Updated

13 Apr, 2025

Data

Company Financials +

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

US$74.94
FV
29.5% undervalued intrinsic discount
12.30%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
4 days ago author updated this narrative

Doximity, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Doximity
Historical stock prices
Current Share PriceUS$52.85
52 Week HighUS$85.21
52 Week LowUS$22.96
Beta1.41
1 Month Change-16.61%
3 Month Change6.32%
1 Year Change104.29%
3 Year Change5.05%
5 Year Changen/a
Change since IPO-0.28%

Recent News & Updates

Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

Apr 04
Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Feb 23
What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10

Recent updates

Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

Apr 04
Shareholders Are Optimistic That Doximity (NYSE:DOCS) Will Multiply In Value

What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Feb 23
What Doximity, Inc.'s (NYSE:DOCS) 28% Share Price Gain Is Not Telling You

Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10

When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Jan 24
When Should You Buy Doximity, Inc. (NYSE:DOCS)?

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Jan 13

Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Jan 06
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Dec 06

Doximity (NYSE:DOCS) Knows How To Allocate Capital

Dec 01
Doximity (NYSE:DOCS) Knows How To Allocate Capital

Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Nov 13
Earnings Not Telling The Story For Doximity, Inc. (NYSE:DOCS) After Shares Rise 34%

Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Nov 02
Does This Valuation Of Doximity, Inc. (NYSE:DOCS) Imply Investors Are Overpaying?

Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Oct 15
Is Doximity, Inc. (NYSE:DOCS) Potentially Undervalued?

Doximity: Downgrade To Hold On Valuation Concerns

Oct 03

Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors

Sep 23
Here's Why Doximity (NYSE:DOCS) Has Caught The Eye Of Investors
author-image

Generative AI And Digital Health Innovations Fuel Robust Revenue Growth And Market Expansion

Aug 28 Accelerating adoption of new products and a client portal, alongside strategic positioning with top clients, suggests sustained revenue expansion.

There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Aug 18
There's Reason For Concern Over Doximity, Inc.'s (NYSE:DOCS) Massive 27% Price Jump

Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Aug 10
Doximity (NYSE:DOCS) Looks To Prolong Its Impressive Returns

Doximity Faces Slower Revenue Growth As R&D Costs May Rise

Jul 23

Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

Jul 23
Is Doximity, Inc. (NYSE:DOCS) Trading At A 23% Discount?

At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Jul 01
At US$27.97, Is It Time To Put Doximity, Inc. (NYSE:DOCS) On Your Watch List?

Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Jun 09
Optimistic Investors Push Doximity, Inc. (NYSE:DOCS) Shares Up 26% But Growth Is Lacking

Doximity Earnings: Better Than Expected, But Still Mixed Outlook (Rating Upgrade)

May 17

Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

May 04
Capital Allocation Trends At Doximity (NYSE:DOCS) Aren't Ideal

Doximity: Significant Upside Remains, But Not Until The Growth Story Returns

Apr 29

With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Apr 16
With Doximity, Inc. (NYSE:DOCS) It Looks Like You'll Get What You Pay For

Doximity: Rating Upgrade To Buy As Outlook Turns Positive

Feb 21

Doximity: Downside Is Contained, While Upside Depends On Management's Game Plan

Jan 16

Doximity Earnings: Steer Clear Of This Rollercoaster War Of Optimism Vs. Skepticism

Nov 10

Doximity: Adding Value Using AI But Faces Near-Term Risks

Nov 01

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

Aug 24

Doximity Earnings: Too Many Problems, Sell

Aug 09

Doximity: Continue To See Positive Upside From Current Stock Level

Jul 05

Shareholder Returns

DOCSUS Healthcare ServicesUS Market
7D3.1%4.3%5.4%
1Y104.3%-0.7%3.6%

Return vs Industry: DOCS exceeded the US Healthcare Services industry which returned -0.7% over the past year.

Return vs Market: DOCS exceeded the US Market which returned 3.6% over the past year.

Price Volatility

Is DOCS's price volatile compared to industry and market?
DOCS volatility
DOCS Average Weekly Movement12.9%
Healthcare Services Industry Average Movement12.3%
Market Average Movement7.7%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market4.0%

Stable Share Price: DOCS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: DOCS's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2010827Jeff Tangneywww.doximity.com

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems.

Doximity, Inc. Fundamentals Summary

How do Doximity's earnings and revenue compare to its market cap?
DOCS fundamental statistics
Market capUS$9.92b
Earnings (TTM)US$201.35m
Revenue (TTM)US$550.17m

49.3x

P/E Ratio

18.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DOCS income statement (TTM)
RevenueUS$550.17m
Cost of RevenueUS$53.97m
Gross ProfitUS$496.19m
Other ExpensesUS$294.85m
EarningsUS$201.35m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.07
Gross Margin90.19%
Net Profit Margin36.60%
Debt/Equity Ratio0%

How did DOCS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/13 00:48
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Doximity, Inc. is covered by 27 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vikram KesavabhotlaBaird
Nisala WeerasuriyaBerenberg
Allen LutzBofA Global Research